Predicting outcomes in cervical cancer: a kinetic model of tumor regression during radiation therapy.

Abstract:

:Applications of mathematical modeling can improve outcome predictions of cancer therapy. Here we present a kinetic model incorporating effects of radiosensitivity, tumor repopulation, and dead-cell resolving on the analysis of tumor volume regression data of 80 cervical cancer patients (stages 1B2-IVA) who underwent radiation therapy. Regression rates and derived model parameters correlated significantly with clinical outcome (P < 0.001; median follow-up: 6.2 years). The 6-year local tumor control rate was 87% versus 54% using radiosensitivity (2-Gy surviving fraction S(2) < 0.70 vs. S(2) > or = 0.70) as a predictor (P = 0.001) and 89% vs. 57% using dead-cell resolving time (T(1/2) < 22 days versus T(1/2) > or = 22 days, P < 0.001). The 6-year disease-specific survival was 73% versus 41% with S(2) < 0.70 versus S(2) > or = 0.70 (P = 0.025), and 87% vs. 52% with T(1/2) < 22 days versus T(1/2) > or = 22 days (P = 0.002). Our approach illustrates the promise of volume-based tumor response modeling to improve early outcome predictions that can be used to enable personalized adaptive therapy.

journal_name

Cancer Res

journal_title

Cancer research

authors

Huang Z,Mayr NA,Yuh WT,Lo SS,Montebello JF,Grecula JC,Lu L,Li K,Zhang H,Gupta N,Wang JZ

doi

10.1158/0008-5472.CAN-09-2501

subject

Has Abstract

pub_date

2010-01-15 00:00:00

pages

463-70

issue

2

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-09-2501

journal_volume

70

pub_type

杂志文章
  • Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody.

    abstract::DNA topoisomerase I (topo I) has been identified as a principal target of a plant alkaloid camptothecin (CPT) and its derivative (CPT-11). The latter compound is expected to be a clinically useful antitumor agent. Three human tumor cell lines resistant to CPT (A549/CPT, HT-29/CPT, St-4/CPT) were isolated in vitro, and...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sugimoto Y,Tsukahara S,Oh-hara T,Isoe T,Tsuruo T

    更新日期:1990-11-01 00:00:00

  • The Endosomal Protein CEMIP Links WNT Signaling to MEK1-ERK1/2 Activation in Selumetinib-Resistant Intestinal Organoids.

    abstract::MAPK signaling pathways are constitutively active in colon cancer and also promote acquired resistance to MEK1 inhibition. Here, we demonstrate that BRAFV600E -mutated colorectal cancers acquire resistance to MEK1 inhibition by inducing expression of the scaffold protein CEMIP through a β-catenin- and FRA-1-dependent ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-3149

    authors: Duong HQ,Nemazanyy I,Rambow F,Tang SC,Delaunay S,Tharun L,Florin A,Büttner R,Vandaele D,Close P,Marine JC,Shostak K,Chariot A

    更新日期:2018-08-15 00:00:00

  • Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.

    abstract::Gonadotropin-releasing hormone (GnRH) receptor agonists are extensively used in the treatment of sex hormone-dependent cancers via the desensitization of pituitary gonadotropes and consequent decrease in steroid sex hormone secretion. However, evidence now points to a direct inhibitory effect of GnRH analogs on cancer...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1360

    authors: Maudsley S,Davidson L,Pawson AJ,Chan R,López de Maturana R,Millar RP

    更新日期:2004-10-15 00:00:00

  • Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.

    abstract::For many solid tumors, surgical resection remains the gold standard and tumor-involved margins are associated with poor clinical outcomes. Near-infrared (NIR) fluorescence imaging using molecular agents has shown promise for in situ imaging during resection. However, for cancers with difficult imaging conditions, surg...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-0878

    authors: Gao RW,Teraphongphom NT,van den Berg NS,Martin BA,Oberhelman NJ,Divi V,Kaplan MJ,Hong SS,Lu G,Ertsey R,Tummers WSFJ,Gomez AJ,Holsinger FC,Kong CS,Colevas AD,Warram JM,Rosenthal EL

    更新日期:2018-09-01 00:00:00

  • Age-dependent cell inactivation by vincristine alone or in combination with 1-propargyl-5-chloropyrimidin-2-one.

    abstract::Inactivating effects caused by vincristine alone or in combination with another mitotic inhibitor, 1-propargyl-5-chloropyrimidin-2-one, were studied as loss of colony-forming ability in exponentially growing or synchronized populations of the human cell line NHIK 3025. Treatment with 4 ng vincristine per ml(4.3 nM) in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wibe E

    更新日期:1980-06-01 00:00:00

  • Tumor necrosis factor in children with malignancies.

    abstract::We measured serum tumor necrosis factor alpha (TNF) concentrations by a double-antibody radioimmunoassay method, with a detection level of 10 ng/liter, in 32 children with malignancies. Seventeen had acute lymphoblastic leukemia, 4 had acute nonlymphocytic leukemia, and 11 had solid tumors. At the diagnosis of maligna...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Saarinen UM,Koskelo EK,Teppo AM,Siimes MA

    更新日期:1990-02-01 00:00:00

  • Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer.

    abstract::MEK inhibition is of interest in cancer drug development, but clinical activity in metastatic colorectal cancer (mCRC) has been limited. Preclinical studies demonstrated Wnt pathway overexpression in KRAS-mutant cell lines resistant to the MEK inhibitor, selumetinib. The combination of selumetinib and cyclosporin A, a...

    journal_title:Cancer research

    pub_type: 杂志文章,多中心研究

    doi:10.1158/0008-5472.CAN-18-0316

    authors: Krishnamurthy A,Dasari A,Noonan AM,Mehnert JM,Lockhart AC,Leong S,Capasso A,Stein MN,Sanoff HK,Lee JJ,Hansen A,Malhotra U,Rippke S,Gustafson DL,Pitts TM,Ellison K,Davis SL,Messersmith WA,Eckhardt SG,Lieu CH

    更新日期:2018-09-15 00:00:00

  • Role of the prostaglandin E2 receptor in mammary tumor metastasis.

    abstract::Both clinical and experimental breast tumors often synthesize high levels of prostaglandins, most notably prostaglandin E2 (PGE2). We have reported previously that metastatic murine mammary tumor cells also express a high-affinity PGE2 receptor. We have now shown that the receptor plays a functional role in the metast...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fulton AM,Zhang SZ,Chong YC

    更新日期:1991-04-15 00:00:00

  • Development of an in vitro infectivity assay for the C-type bovine leukemia virus.

    abstract::The ability of the bovine C-type leukemia virus to induce syncytia formation in monolayer cell cultures has been used to develop a specific and simple infectivity assay for the virus. Using bovine embryonic spleen cells or human diploid embryonic lung cells as indicator cells, the results of the assay can be evaluated...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ferrer JF,Diglio CA

    更新日期:1976-03-01 00:00:00

  • Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin.

    abstract::Malignant pleural mesothelioma is a relatively uncommon and yet incurable tumor. The pathogenesis of mesothelioma remains poorly understood. This study evaluated the role of Wnt signaling in mesothelioma. Western blot analysis was conducted to confirm the expression of Dishevelled (Dvl) and cytosolic beta-catenin in m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Uematsu K,Kanazawa S,You L,He B,Xu Z,Li K,Peterlin BM,McCormick F,Jablons DM

    更新日期:2003-08-01 00:00:00

  • Carbamyl phosphate synthetases in rat liver neoplasms.

    abstract::Isozymes of carbamyl phosphate synthetase (CPS), CPS I, a mitochondrial enzyme found exclusively in liver and involved in urea synthesis, and of CPS II, a soluble cytoplasmic enzyme widely distributed in animal tissues, were assayed in rat liver and in a series of rat liver neoplasms ranging widely in growth rate and ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lawson D,Paik WK,Morris HP,Weinhouse S

    更新日期:1975-01-01 00:00:00

  • Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.

    abstract::We have previously described the neoplastic transformation of immortalized human bronchial epithelial cells (BEAS-2B) by the combination of the c-raf-1 and c-myc protooncogenes and the concomitant induction of neuron-specific enolase mRNA expression (A. Pfeifer et al., Proc. Natl. Acad. Sci. USA, 86: 10075-10079, 1989...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pfeifer AM,Jones RT,Bowden PE,Mann D,Spillare E,Klein-Szanto AJ,Trump BF,Harris CC

    更新日期:1991-07-15 00:00:00

  • Limited capability of regional lymph nodes to eradicate metastatic cancer cells.

    abstract::The capacity of lymph nodes to eradicate cancer is a controversial issue. The purpose of this study was to determine the interplay between tumor growth and host resistance at early stages of lymph node metastasis. A metastasis model was made in the rat mesenteric lymph node, and migration of cancer cells was visualize...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1182

    authors: Nagata H,Arai T,Soejima Y,Suzuki H,Ishii H,Hibi T

    更新日期:2004-11-15 00:00:00

  • Caspase-8: fly or die.

    abstract::Recent studies have revealed that procaspase-8 has an important function in cell adhesion and motility. Src phosphorylation controls this function by preventing the conversion of procaspase-8, which is an adhesion/migration factor, to mature caspase-8, which is an apoptosis-inducing factor. This provides a mechanism t...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-08-0952

    authors: Frisch SM

    更新日期:2008-06-15 00:00:00

  • Identification of Interacting Stromal Axes in Triple-Negative Breast Cancer.

    abstract::Triple-negative breast cancer (TNBC) is a molecularly heterogeneous cancer that is difficult to treat. Despite the role it may play in tumor progression and response to therapy, microenvironmental (stromal) heterogeneity in TNBC has not been well characterized. To address this challenge, we investigated the transcript...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-3427

    authors: Saleh SMI,Bertos N,Gruosso T,Gigoux M,Souleimanova M,Zhao H,Omeroglu A,Hallett MT,Park M

    更新日期:2017-09-01 00:00:00

  • Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer.

    abstract::The ErbB2 (Neu) receptor tyrosine kinase is frequently overexpressed in human breast cancers, and this phenotype correlates with a poor clinical prognosis. We examined the effects of the mammalian target of rapamycin inhibitor, rapamycin, on mammary tumorigenesis in transgenic mice bearing an activated ErbB2 (NeuYD) t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-4589

    authors: Liu M,Howes A,Lesperance J,Stallcup WB,Hauser CA,Kadoya K,Oshima RG,Abraham RT

    更新日期:2005-06-15 00:00:00

  • DNA synthesis in tumor-bearing rats.

    abstract::Thmidine (TdR) incorporation into DNA increased in the livers and spleens of rats bearing Yoshida sarcoma (solid type) or AH130 (solid type). TdR kinase and DNA polymerase activities increased in the serum, liver, and spleen of these rats, while thymidine monophosphate kinase activity increased appreciably only in the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shirasaka T,Fujii S

    更新日期:1975-03-01 00:00:00

  • miRNA-708 control of CD44(+) prostate cancer-initiating cells.

    abstract::Tumor recurrence in prostate cancer has been attributed to the presence of CD44-expressing tumor-initiating cells. In this study, we report that miR-708 is a key negative regulator of this CD44(+) subpopulation of prostate cancer cells, with important implications for diagnosis and prognosis of this disease. miR-708 w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-0540

    authors: Saini S,Majid S,Shahryari V,Arora S,Yamamura S,Chang I,Zaman MS,Deng G,Tanaka Y,Dahiya R

    更新日期:2012-07-15 00:00:00

  • Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib.

    abstract::There is an unmet need for pharmacodynamic and predictive biomarkers for antiangiogenic agents. Recent studies have shown that soluble vascular endothelial growth factor receptor 2 (sVEGFR2), VEGF, and several other soluble factors may be modulated by VEGF pathway inhibitors. We conducted a broad profiling of cytokine...

    journal_title:Cancer research

    pub_type: 杂志文章,多中心研究

    doi:10.1158/0008-5472.CAN-09-2533

    authors: Nikolinakos PG,Altorki N,Yankelevitz D,Tran HT,Yan S,Rajagopalan D,Bordogna W,Ottesen LH,Heymach JV

    更新日期:2010-03-15 00:00:00

  • Coupling of mutated Met variants to DNA repair via Abl and Rad51.

    abstract::Abnormal activation of DNA repair pathways by deregulated signaling of receptor tyrosine kinase systems is a compelling likelihood with significant implications in both cancer biology and treatment. Here, we show that due to a potential substrate switch, mutated variants of the receptor for hepatocyte growth factor Me...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1269

    authors: Ganapathipillai SS,Medová M,Aebersold DM,Manley PW,Berthou S,Streit B,Blank-Liss W,Greiner RH,Rothen-Rutishauser B,Zimmer Y

    更新日期:2008-07-15 00:00:00

  • The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.

    abstract::Available evidence suggests that, among hematological malignancies, p53 is most often mutated in Burkitt's lymphoma (BL). However, much of the published data is based on cell lines. We have, therefore, analyzed BL biopsies to determine more accurately the frequency and pattern of p53 mutations in primary tumors and to...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bhatia KG,Gutiérrez MI,Huppi K,Siwarski D,Magrath IT

    更新日期:1992-08-01 00:00:00

  • Differences in glycosylation state of fibronectin from two rat colon carcinoma cell lines in relation to tumoral progressiveness.

    abstract::We have investigated the biosynthesis and carbohydrate structure of fibronectin secreted by two rat colon carcinoma cell lines. The cell line Prob yields progressive tumors after s.c. injection in syngeneic BD IX rats while tumors developed by Regb cells disappear after 20 days. No difference was observed in the fibro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kasbaoui L,Harb J,Bernard S,Meflah K

    更新日期:1989-10-01 00:00:00

  • Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin 2 therapy.

    abstract::The present work is a continuation of our studies to improve the graft versus leukemia (GVL) effect in autologous bone marrow transplantation. We have recently shown that the GVL effect of bone marrow transplantation (BMT) with interleukin 2 (IL-2)-activated bone marrow (ABM) followed by IL-2 therapy immediately after...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Charak BS,Brynes RK,Katsuda S,Groshen S,Chen SC,Mazumder A

    更新日期:1991-04-15 00:00:00

  • 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.

    abstract::3-(Iodoacetamido)-benzoylurea (3-IAABU) is a newly synthesized antitubulin compound with a molecular weight of 347. 3-IAABU exhibited anticancer activity in a variety of tumor cell lines with ID90 in the range of 0.015-0.29 microM for leukemic cells and 0.06-0.92 microM for solid tumors. Higher selectivity against mal...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jiang JD,Davis AS,Middleton K,Ling YH,Perez-Soler R,Holland JF,Bekesi JG

    更新日期:1998-12-01 00:00:00

  • Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.

    abstract::Our recent study found that activation of signal transducer and activator of transcription 3 (Stat3) is up-regulated in human brain metastatic cells and contributes to brain metastasis of melanoma. However, the molecular mechanisms underlying this increased Stat3 activation and effect on brain metastasis are unknown. ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1429

    authors: Huang FJ,Steeg PS,Price JE,Chiu WT,Chou PC,Xie K,Sawaya R,Huang S

    更新日期:2008-12-01 00:00:00

  • Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.

    abstract::Tumor antigen-induced inhibition of leukocyte adherence was adapted and modified for use in glass test tubes for the study of cell-mediated antitumor immunity to human adenocarcinoma of the breast. Peripheral blood leukocytes from 40 to 47 patients with proven breast cancer responded to an antigenic extract of breast ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Grosser N,Thomson DM

    更新日期:1975-09-01 00:00:00

  • The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis.

    abstract::Spy1A is a unique cell cycle activator known to mediate cell cycle progression and override the DNA damage response. This study focused on determining the role of this protein on postnatal mammary gland morphogenesis and neoplasia. Herein, we show that Spy1A levels are tightly regulated during mammary gland developmen...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6453

    authors: Golipour A,Myers D,Seagroves T,Murphy D,Evan GI,Donoghue DJ,Moorehead RA,Porter LA

    更新日期:2008-05-15 00:00:00

  • Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.

    abstract::Analysis of leukemic cell phenotypes using cell surface antigens and various enzymes indicates that acute lymphoblastic leukemia (ALL) is a biologically heterogeneous disease consisting of four major subclasses with additional subsets existing within these subclasses. These different types of ALL appear to reflect seq...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Greaves MF

    更新日期:1981-11-01 00:00:00

  • Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells.

    abstract::Interleukin-6 (IL-6) and the subsequent Janus-activated kinase (JAK)-dependent signaling pathways play a critical role in the pathogenesis of multiple myeloma. Here, we compared the sensitivity and specificity of a novel pan-JAK inhibitor, tetracyclic pyridone 6 (P6), with that of AG490 in a panel of myeloma-derived c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4280

    authors: Pedranzini L,Dechow T,Berishaj M,Comenzo R,Zhou P,Azare J,Bornmann W,Bromberg J

    更新日期:2006-10-01 00:00:00

  • Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.

    abstract::PTEN loss or PI3K/AKT signaling pathway activation correlates with human prostate cancer progression and metastasis. However, in preclinical murine models, deletion of Pten alone fails to mimic the significant metastatic burden that frequently accompanies the end stage of human disease. To identify additional pathway ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3132

    authors: Mulholland DJ,Kobayashi N,Ruscetti M,Zhi A,Tran LM,Huang J,Gleave M,Wu H

    更新日期:2012-04-01 00:00:00